Pathogenesis of liver cirrhosis.

Liver cirrhosis is the final pathological result of various chronic liver diseases, and fibrosis is the precursor of cirrhosis. Many types of cells, cytokines and miRNAs are involved in the initiation and progression of liver fibrosis and cirrhosis. Activation of hepatic stellate cells (HSCs) is a pivotal event in fibrosis. Defenestration and capillarization of liver sinusoidal endothelial cells are major contributing factors to hepatic dysfunction in liver cirrhosis. Activated Kupffer cells destroy hepatocytes and stimulate the activation of HSCs. Repeated cycles of apoptosis and regeneration of hepatocytes contribute to pathogenesis of cirrhosis. At the molecular level, many cytokines are involved in mediation of signaling pathways that regulate activation of HSCs and fibrogenesis. Recently, miRNAs as a post-transcriptional regulator have been found to play a key role in fibrosis and cirrhosis. Robust animal models of liver fibrosis and cirrhosis, as well as the recently identified critical cellular and molecular factors involved in the development of liver fibrosis and cirrhosis will facilitate the development of more effective therapeutic approaches for these conditions.

[1]  E. Wisse,et al.  An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. , 1970, Journal of ultrastructure research.

[2]  H. Tsukamoto,et al.  Sensitization of hepatic lipocytes by high‐fat diet to stimulatory effects of kupffer cell‐derived factors: Implication in alcoholic liver fibrogenesis , 1990, Hepatology.

[3]  Yoshiki Murakami,et al.  The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families , 2011, PloS one.

[4]  A. Benedetti,et al.  An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver , 2004, Virchows Archiv.

[5]  H. Nishina,et al.  Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells. , 2014, Tissue engineering. Part B, Reviews.

[6]  Kazuo Ikeda,et al.  Induction of microRNA-214-5p in human and rodent liver fibrosis , 2012, Fibrogenesis & tissue repair.

[7]  Wei Wu,et al.  Efficacy of HGF carried by ultrasound microbubble-cationic nano-liposomes complex for treating hepatic fibrosis in a bile duct ligation rat model, and its relationship with the diffusion-weighted MRI parameters. , 2013, Clinics and research in hepatology and gastroenterology.

[8]  Yanqiu Wang,et al.  Probucol attenuates ethanol‐induced liver fibrosis in rats by inhibiting oxidative stress, extracellular matrix protein accumulation and cytokine production , 2014, Clinical and experimental pharmacology & physiology.

[9]  Terry M. Therneau,et al.  Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.

[10]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[11]  Cheng Huang,et al.  The potential of microRNAs in liver fibrosis. , 2012, Cellular signalling.

[12]  R. Saller,et al.  The Use of Silymarin in the Treatment of Liver Diseases , 2012, Drugs.

[13]  A. Scheynius,et al.  Kupffer cell iron overload induces intercellular adhesion molecule‐1 expression on hepatocytes in genetic hemochromatosis , 1995, Hepatology.

[14]  Z. Kmieć,et al.  Cooperation of Liver Cells in Health and Disease , 2001, Advances in Anatomy Embryology and Cell Biology.

[15]  T. Luedde,et al.  Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis , 2012, PloS one.

[16]  J. Sheng,et al.  Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis. , 2013, World journal of gastroenterology.

[17]  K. Jeong,et al.  Hypoxia potentiates transforming growth factor‐β expression of hepatocyte during the cirrhotic condition in rat liver , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[18]  A. Gressner,et al.  Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis. , 2004, Biochemical and biophysical research communications.

[19]  J. Dranoff,et al.  Autocrine release of TGF‐β by portal fibroblasts regulates cell growth , 2004 .

[20]  M. Shiao,et al.  Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats. , 2005, Journal of biomedical science.

[21]  J. Iredale,et al.  Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation , 1999, Hepatology.

[22]  M. Serdar,et al.  The effect of taurine treatment on oxidative stress in experimental liver fibrosis. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[23]  Xiao-feng Shi,et al.  The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. , 2011, Biochemical and biophysical research communications.

[24]  William M. Lee,et al.  Screening for Wilson disease in acute liver failure: A comparison of currently available diagnostic tests , 2008, Hepatology.

[25]  L. Sobin,et al.  The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. , 1978, Journal of clinical pathology.

[26]  Junfeng Zhang,et al.  3,3′‐Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR‐21 expression , 2013, British journal of pharmacology.

[27]  S. Friedman The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[28]  M. Manns,et al.  Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis , 2002 .

[29]  C. Camaschella Treating iron overload. , 2013, The New England journal of medicine.

[30]  D. Schuppan,et al.  Hepatitis C and liver fibrosis , 2003, Cell Death and Differentiation.

[31]  Y. Inagaki,et al.  Treatment strategy for liver fibrosis through recruitment and differentiation of bone marrow stem/progenitor cells , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[32]  Y. Yamori,et al.  Dysregulated Bile Acid Synthesis, Metabolism and Excretion in a High Fat-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats , 2013, Digestive Diseases and Sciences.

[33]  G. Kolios,et al.  Role of Kupffer cells in the pathogenesis of liver disease. , 2006, World journal of gastroenterology.

[34]  Gennaro Ciliberto,et al.  Increased toxin‐induced liver injury and fibrosis in interleukin‐6–deficient mice , 2000, Hepatology.

[35]  Xing-kai Meng,et al.  Development of a New Animal Model of Liver Cirrhosis in Swine , 2008, European Surgical Research.

[36]  B. Comert,et al.  Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis. , 2008, World journal of gastroenterology.

[37]  P. Mulder,et al.  Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis. , 2007, Journal of hepatology.

[38]  X. Hou,et al.  Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: A double-blind randomized controlled trial , 2013, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[39]  D. Stolz,et al.  Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver , 2007, Hepatology.

[40]  Yao Tong,et al.  Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[41]  Shi-jun Chen,et al.  Expression of Interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection , 2013, Diagnostic Pathology.

[42]  T. Luedde,et al.  miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. , 2013, Journal of hepatology.

[43]  D. Schuppan,et al.  Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment. , 2013, Journal of hepatology.

[44]  N. Delibaş,et al.  Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results. , 2013, Clinics and research in hepatology and gastroenterology.

[45]  C. J. Marek,et al.  Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. , 2005, Gastroenterology.

[46]  G. Escobedo,et al.  Th2-Associated Alternative Kupffer Cell Activation Promotes Liver Fibrosis without Inducing Local Inflammation , 2011, International journal of biological sciences.

[47]  D. Jiang,et al.  HGF inhibits TGF-β1-induced myofibroblast differentiation and ECM deposition via MMP-2 in Achilles tendon in rat , 2011, European Journal of Applied Physiology.

[48]  A. Colao,et al.  Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. , 2011, Journal of biological regulators and homeostatic agents.

[49]  F. Oakley,et al.  The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis , 2005, Apoptosis.

[50]  Q. Fa-zu,et al.  Studies on hepatocyte apoptosis, proliferation and oncogene c-fos expression in carbon tetrachloride-induced cirrhotic rat liver , 2008, Journal of Tongji Medical University.

[51]  Y. Popov Mouse model of primary biliary cirrhosis with progressive fibrosis: Are we there yet? , 2013, Hepatology.

[52]  J. Kountouras,et al.  Colchicine treatment of liver fibrosis. , 2006, Hepato-gastroenterology.

[53]  S. Pianko,et al.  Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection , 2000, Journal of gastroenterology and hepatology.

[54]  Y. N. Park,et al.  Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression , 2010, Hepatology international.

[55]  Yi‐Chen Chen,et al.  Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. , 2012, Journal of the science of food and agriculture.

[56]  N. Kawada,et al.  Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells , 2009, Hepatology international.

[57]  P. Boor,et al.  Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis. , 2013, The American journal of pathology.

[58]  Douglas A. Simonetto,et al.  Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. , 2014, Gastroenterology.

[59]  G. Brewer,et al.  Improvement in Dissolution of Liver Fibrosis in an Animal Model by Tetrathiomolybdate , 2009, Experimental biology and medicine.

[60]  Filip Braet,et al.  Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review , 2002, Comparative hepatology.

[61]  J. Miquel,et al.  Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis , 2007, Journal of gastroenterology and hepatology.

[62]  B. Violand,et al.  Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[63]  T. Okanoue,et al.  Role of sinusoidal endothelial cells in liver disease , 1995, Journal of gastroenterology and hepatology.

[64]  James Q. Yin,et al.  Therapeutic strategies against TGF‐β signaling pathway in hepatic fibrosis , 2006 .

[65]  H. Ueno,et al.  Inhibitory effect of a soluble transforming growth factor beta type II receptor on the activation of rat hepatic stellate cells in primary culture. , 2003, Journal of hepatology.

[66]  R. Perez-Tamayo,et al.  Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver. , 2006, Experimental and molecular pathology.

[67]  Li-juan Zhang,et al.  Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats. , 2006, World journal of gastroenterology.

[68]  Tao Yu,et al.  Effect of rat serum containing Biejiajian oral liquid on proliferation of rat hepatic stellate cells. , 2004, World journal of gastroenterology.

[69]  Y. Ngo,et al.  Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials. , 2009, Gastroenterologie clinique et biologique.

[70]  Y. Chrétien,et al.  Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis , 2006, Hepatology.

[71]  D. Jäger,et al.  Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice. , 2012, Journal of hepatology.

[72]  Y. Liaw,et al.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update , 2008, Hepatology international.

[73]  S. Hung,et al.  The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[74]  J. Reichen,et al.  Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. , 2006, Journal of hepatology.

[75]  G. Ji,et al.  Effect of Chinese medicine Qinggan Huoxuefang on inducing HSC apoptosis in alcoholic liver fibrosis rats. , 2006, World journal of gastroenterology.

[76]  Y. Perrie,et al.  Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis , 2011, Journal of drug targeting.

[77]  Youxin Jin,et al.  Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats , 2006, The journal of gene medicine.

[78]  M. Tsai,et al.  Phyto-power dietary supplement potently inhibits dimethylnitrosamine-induced liver fibrosis in rats. , 2013, Food & function.

[79]  H. Cortez‐Pinto,et al.  Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients , 2004, The American Journal of Gastroenterology.

[80]  K. Guo,et al.  miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. , 2012, Biochemical and biophysical research communications.

[81]  PDGF and signal transduction in hepatic stellate cells. , 2002 .

[82]  K. Goh,et al.  Liver cirrhosis in Malaysia: Peculiar epidemiology in a multiracial Asian country , 2011, Journal of gastroenterology and hepatology.

[83]  X. Coumoul,et al.  Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[84]  D. Stolz Sinusoidal Endothelial Cells , 2011 .

[85]  J. Spitzer,et al.  Hepatic sinusoidal endothelial cell in alcoholemia and endotoxemia. , 1996, Alcoholism, clinical and experimental research.

[86]  S. Vowler,et al.  Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. , 2005, Gastroenterology.

[87]  A. Gressner,et al.  Pro-fibrogenic potential of PDGF-D in liver fibrosis. , 2007, Journal of hepatology.

[88]  Ioannis I. Stamoulis,et al.  Platelet-Activating Factor Involvement in Thioacetamide-Induced Experimental Liver Fibrosis and Cirrhosis , 2010, Digestive Diseases and Sciences.

[89]  A. Concejero,et al.  Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation , 2006, Acta Pharmacologica Sinica.

[90]  Edoardo Cervoni,et al.  Hepatitis C , 1998, The Lancet.

[91]  R. Malekzadeh,et al.  Impact of Immunosuppressive Treatment on Liver Fibrosis in Autoimmune Hepatitis , 2005, Digestive Diseases and Sciences.

[92]  R Weiskirchen,et al.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets , 2006, Journal of cellular and molecular medicine.

[93]  A. Işık,et al.  Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis. , 2007, World journal of gastroenterology.

[94]  R. Coppel,et al.  Primary biliary cirrhosis , 2011, The Lancet.

[95]  E. De Clercq,et al.  Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir. , 2007, Antiviral research.

[96]  C. Liu,et al.  Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. , 2002, World journal of gastroenterology.

[97]  Ying-Jan Wang,et al.  α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β. , 2011, Toxicology.

[98]  K. Yoshimura,et al.  Recent advances in liver sinusoidal endothelial ultrastructure and fine structure immunocytochemistry. , 2012, Micron.

[99]  M. Sherman,et al.  Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. , 2000, Archives of pathology & laboratory medicine.

[100]  B. Saile The bcl, NFκB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-β or TNF-α on activated hepatic stellate cells , 2001 .

[101]  R. Malekzadeh,et al.  Review article: the reversibility of cirrhosis , 2012, Alimentary pharmacology & therapeutics.

[102]  R. Mahato,et al.  Gene modulation for treating liver fibrosis. , 2007, Critical reviews in therapeutic drug carrier systems.

[103]  B. Bacon,et al.  Hereditary hemochromatosis in the post‐HFE era , 2008, Hepatology.

[104]  S. Friedman,et al.  Hepatic fibrosis--role of hepatic stellate cell activation. , 2002, MedGenMed : Medscape general medicine.

[105]  G. Kanel,et al.  Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. , 2012, Gastroenterology.

[106]  L. Packer,et al.  α-Lipoic Acid , 2000 .

[107]  J. Lunz,et al.  An inhibitor of cyclin‐dependent kinase, stress‐induced p21Waf‐1/Cip‐1, mediates hepatocyte mito‐inhibition during the evolution of cirrhosis , 2005, Hepatology.

[108]  Yong-ri Jin,et al.  Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha. , 2005, World journal of gastroenterology.

[109]  D. Bar-Sagi,et al.  In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. , 2009, The Journal of clinical investigation.

[110]  G. Gores,et al.  Activated stellate cells express the TRAIL receptor‐2/death receptor‐5 and undergo TRAIL‐mediated apoptosis , 2003, Hepatology.

[111]  H. Tsukamoto,et al.  Stimulation of hepatic lipocyte collagen production by Kupffer cell‐derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis , 1990, Hepatology.

[112]  Fortunato,et al.  Alcohol-induced sinusoidal endothelial cell dysfunction in the mouse is associated with exacerbated liver apoptosis and can be reversed by caspase inhibition. , 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

[113]  K. Tsuneyama,et al.  Innate immunity and primary biliary cirrhosis: Activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis , 2011, Hepatology.

[114]  G. Ramadori,et al.  Interferon-gamma acts proapoptotic on hepatic stellate cells (HSC) and abrogates the antiapoptotic effect of interferon-alpha by an HSP70-dependant pathway. , 2005, European journal of cell biology.

[115]  H. Bonkovsky,et al.  Inhibitory effects of microRNA 19b in hepatic stellate cell‐mediated fibrogenesis , 2012, Hepatology.

[116]  G. Gores,et al.  Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression , 2003, Hepatology.

[117]  I. Barshack,et al.  Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. , 2011, Journal of hepatology.

[118]  L. Ferrell Liver Pathology: Cirrhosis, Hepatitis, and Primary Liver Tumors. Update and Diagnostic Problems , 2000, Modern Pathology.

[119]  P. Schirmacher,et al.  Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A. , 2008, Gene.

[120]  M. Zern,et al.  Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats. , 2008, Liver.

[121]  V. Alves,et al.  S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis , 2013, Drug design, development and therapy.

[122]  Cheng-Hai Liu,et al.  Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro , 2013, Experimental biology and medicine.

[123]  Natalie J Torok,et al.  Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[124]  B. Gao,et al.  Interleukin‐22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice , 2012, Hepatology.

[125]  D. Schuppan,et al.  Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[126]  R. Urtasun,et al.  Osteopontin induces ductular reaction contributing to liver fibrosis , 2014, Gut.

[127]  K. Okita,et al.  Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. , 2004, Biochemical and biophysical research communications.

[128]  Wen-Chuan Lin,et al.  Post‐treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice , 2009, Phytotherapy research : PTR.

[129]  J. Crespo,et al.  Plasma Leptin and TNF-α Levels in Chronic Hepatitis C Patients and Their Relationship to Hepatic Fibrosis , 2002, Digestive Diseases and Sciences.

[130]  T. Hibi,et al.  Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice , 2005, Gut.

[131]  V. Tsutsumi,et al.  Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[132]  Rongbo Zhang,et al.  Vitamin E reduces hepatic fibrosis in mice with Schistosoma japonicum infection. , 2011, Molecular medicine reports.

[133]  Chuanlong Zhu,et al.  Inhibitory Effect of Antisense Oligonucleotide Targeting TIMP-2 on Immune-Induced Liver Fibrosis , 2010, Digestive Diseases and Sciences.

[134]  Kun-Lin Yang,et al.  Establishment of an early liver fibrosis model by the hydrodynamics-based transfer of TGF-β1 gene , 2007, Comparative hepatology.

[135]  Shaheen N. Khan,et al.  Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice , 2013, Journal of Translational Medicine.

[136]  I. Kamel,et al.  Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study , 2011, BMJ : British Medical Journal.

[137]  A. Bisceglie Natural history of hepatitis C: its impact on clinical management. , 2000 .

[138]  Hui Wang,et al.  Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats. , 2007, Pharmacological research.

[139]  A. Lok,et al.  Update on viral hepatitis: 2007 , 2008, Current opinion in gastroenterology.

[140]  E. Kouroumalis,et al.  Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells , 2014, Regulatory Peptides.

[141]  M. Odenthal,et al.  Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. , 2013, Journal of hepatology.

[142]  G. Perlemuter,et al.  [Epidemiology and natural history of cirrhosis]. , 2005, La Revue du praticien.

[143]  P. Hayes,et al.  Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: Implications for treatment cost‐effectiveness , 2013, Hepatology.

[144]  Ying-wei Chen,et al.  Tetrandrine inhibits activation of rat hepatic stellate cells in vitro via transforming growth factor-beta signaling. , 2005, World journal of gastroenterology.

[145]  M. Menger,et al.  Microvascular consequences of Kupffer cell modulation in rat liver fibrogenesis , 1999, The Journal of pathology.

[146]  Li-juan Zhang,et al.  Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. , 2007, Hepato-gastroenterology.

[147]  D. Crane,et al.  Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury , 2013, Laboratory Investigation.

[148]  Kaori Fujieda,et al.  Capillarization and venularization of hepatic sinusoids in porcine serum‐induced rat liver fibrosis: A mechanism to maintain liver blood flow , 1993, Hepatology.

[149]  Ming-Fen Lee,et al.  Pterostilbene inhibits dimethylnitrosamine (DMN)‐induced liver fibrosis in rats , 2012, Food chemistry.

[150]  H. Ran,et al.  The treatment of liver fibrosis induced by hepatocyte growth factor-directed, ultrasound-targeted microbubble destruction in rats. , 2009, Clinical imaging.

[151]  Y. Li,et al.  Preventive Effect of Halofuginone on Concanavalin A-Induced Liver Fibrosis , 2013, PloS one.

[152]  K. Kodys,et al.  IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. , 2012, The Journal of clinical investigation.

[153]  K. Wallace,et al.  Interleukin-1 participates in the progression from liver injury to fibrosis. , 2009, American Journal of Physiology - Gastrointestinal and Liver Physiology.

[154]  G. Ramadori,et al.  IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF) , 2004, Laboratory Investigation.

[155]  Y. Tong,et al.  Chinese medicines as a resource for liver fibrosis treatment , 2009, Chinese medicine.

[156]  J. Lin,et al.  Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[157]  A. Benedetti,et al.  Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis , 1996, Hepatology.

[158]  R. Khan,et al.  Update on Viral Hepatitis , 1997, Journal of the Royal College of Physicians of London.

[159]  J. Koskinas,et al.  Autoimmune Hepatitis or Wilson’s Disease, a Clinical Dilemma , 2013, Hepatitis monthly.

[160]  Jianming Xu,et al.  Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats. , 2009, World journal of gastroenterology.

[161]  T. Okanoue,et al.  Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis , 1993, Hepatology.

[162]  Ping Liu Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action , 2012, Chinese Journal of Integrative Medicine.

[163]  A. Chowdhury,et al.  Development of an animal model of hepatic fibrosis by excretory-secretory antigen of Ascaris suum. , 2000, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[164]  A. Colao,et al.  Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. , 2010, World journal of gastroenterology.

[165]  H. Gascan,et al.  Interleukin-33 overexpression is associated with liver fibrosis in mice and humans , 2009, Journal of cellular and molecular medicine.

[166]  W. Hur,et al.  Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis. , 2011, Biomaterials.

[167]  A. Gressner,et al.  Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis , 2004, Laboratory Investigation.

[168]  S. Friedman,et al.  Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. , 1989, The Journal of clinical investigation.

[169]  H. Fujii,et al.  Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. , 2013, The Journal of surgical research.

[170]  K. Orita,et al.  Assessment of Kupffer cell function in rats with chronic liver injury caused by CCl4. , 1990, Hepato-gastroenterology.

[171]  A. Colao,et al.  Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. , 2011, World journal of gastroenterology.

[172]  E. Terzioğlu,et al.  Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]. , 2004, European cytokine network.

[173]  P. Schirmacher,et al.  Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. , 2006, Journal of hepatology.

[174]  T. Kishimoto IL-6: from its discovery to clinical applications. , 2010, International immunology.

[175]  A. Gerbes,et al.  Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2). , 2007, Journal of hepatology.

[176]  S. Du,et al.  Houttuynia cordata inhibits lipopolysaccharide-induced rapid pulmonary fibrosis by up-regulating IFN-γ and inhibiting the TGF-β1/Smad pathway , 2012, International Immunopharmacology.

[177]  L. DeLeve,et al.  Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence , 2008, Hepatology.

[178]  M. Zheng,et al.  A New Strategy for Treatment of Liver Fibrosis , 2012, BioDrugs.

[179]  D. Mukhopadhyay,et al.  Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. , 2010, The Journal of clinical investigation.

[180]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[181]  M. Nam,et al.  Therapeutic effects of hepatocyte growth factor‐overexpressing human umbilical cord blood‐derived mesenchymal stem cells on liver fibrosis in rats , 2014, Cell biology international.

[182]  G. Davis,et al.  Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. , 2000, Gastroenterology.

[183]  K. Iwaisako,et al.  Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. , 2012, Gastroenterology.

[184]  A. Gruhler,et al.  Rat liver sinusoidal endothelial cells (LSECs) express functional low density lipoprotein receptor-related protein-1 (LRP-1). , 2011, Journal of hepatology.

[185]  K. Yoshizato,et al.  MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis , 2012, Gut.

[186]  K. Şahin,et al.  The Treatment with Antibody of TNF-α Reduces the Inflammation, Necrosis and Fibrosis in the Non-alcoholic Steatohepatitis Induced by Methionine- and Choline-deficient Diet , 2008, Inflammation.

[187]  M. Arthur,et al.  Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. , 2002, Gastroenterology.

[188]  D. Ganem,et al.  Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.

[189]  D. Brenner,et al.  Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis , 2001, Seminars in liver disease.

[190]  Feng Li,et al.  Targeted delivery of drugs for liver fibrosis , 2009 .

[191]  M. Varela-Rey,et al.  Glutathione depletion is involved in the inhibition of procollagen α1(I) mRNA levels caused by TNF-α on hepatic stellate cells , 2007 .

[192]  D. Dowling Screening for Wilson's disease in acute liver failure: A comparison of currently available diagnostic tests , 2009, Hepatology.

[193]  Lai Wei,et al.  Inhibitory effect of human interferon‐beta‐1a on activated rat and human hepatic stellate cells , 2010, Journal of gastroenterology and hepatology.

[194]  T. Luedde,et al.  Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis , 2011, Hepatology.

[195]  G. Tarantino,et al.  Could inflammatory markers help diagnose nonalcoholic steatohepatitis? , 2009, European journal of gastroenterology & hepatology.

[196]  A. de Gottardi,et al.  Long-Term Treatment of Bile Duct-Ligated Rats with Rapamycin (Sirolimus) Significantly Attenuates Liver Fibrosis: Analysis of the Underlying Mechanisms , 2005, Journal of Pharmacology and Experimental Therapeutics.

[197]  A. Burt,et al.  Fibrosis and cirrhosis reversibility - molecular mechanisms. , 2008, Clinics in liver disease.